Back | Next |
home / stock / plx / plx message board
Subject | By | Source | When |
---|---|---|---|
Hi Kronberg, | Spideyboy | investorshub | 03/05/2023 6:31:10 AM |
$PLX broke 52W/H. | midastouch017 | investorshub | 03/04/2023 6:37:39 AM |
Thanks Kayaher for posting the Zacks updates to | wgg2 | investorshub | 03/01/2023 8:41:37 PM |
Zacks Updates -- | Kayaker | investorshub | 02/28/2023 5:08:27 PM |
May 9th target by FDA | jcon777 | investorshub | 02/28/2023 4:53:21 PM |
PLX In the U.S.A. Chiesi resubmitted the BLA to | midastouch017 | investorshub | 02/28/2023 10:21:57 AM |
Hello Spideyboy! | Kronberg | investorshub | 02/27/2023 5:49:49 PM |
Protalix BioTherapeutics ($PLX) Q4 2022 Earnings Call Transcript | midastouch017 | investorshub | 02/27/2023 4:23:01 PM |
Protalix BioTherapeutics Reports Fiscal Year 2022 Financial and | midastouch017 | investorshub | 02/27/2023 1:20:11 PM |
Hi Kronberg, | Spideyboy | investorshub | 02/27/2023 1:00:51 PM |
Protalix Undervalued On CHMP Recommendation Of PRX-102 For | midastouch017 | investorshub | 02/27/2023 7:29:47 AM |
Maybe I misinterpreted your idea about OPRX-106. Well | Kronberg | investorshub | 02/26/2023 7:36:03 PM |
On another topic of PRX-102 labelling, | Spideyboy | investorshub | 02/26/2023 1:31:36 PM |
For the record I didn't say that I | Spideyboy | investorshub | 02/26/2023 12:38:40 PM |
I haven't been on this board for a | Kronberg | investorshub | 02/25/2023 4:34:58 PM |
It should be good from here. | jcon777 | investorshub | 02/24/2023 6:30:59 PM |
Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive | midastouch017 | investorshub | 02/24/2023 3:20:17 PM |
Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive | midastouch017 | investorshub | 02/24/2023 3:20:16 PM |
On 23 February 2023, the Committee for Medicinal | midastouch017 | investorshub | 02/24/2023 1:19:16 PM |
We have positive Opinion ?? | pix | investorshub | 02/24/2023 12:04:37 PM |
News, Short Squeeze, Breakout and More Instantly...
Protalix BioTherapeutics Inc. Company Name:
PLX Stock Symbol:
NYSE Market:
Protalix BioTherapeutics Inc. Website:
Protalix BioTherapeutics to Host In-Person Investor Day to Discuss Current Treatment Landscapes and Clinical Results for Fabry Disease and Uncontrolled Gout PR Newswire Event will take place on Wednesday, June 26, 2024 in New York CARMIEL, Israel , J...
Protalix BioTherapeutics to Present at the 2024 BIO International Convention PR Newswire Corporate presentation scheduled for Monday, June 3, 2024 at 2:30 P.M. PDT CARMIEL, Israel , May 29, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc....